HER2/PD1 bispecific antibody in IgG4 subclass with superior anti-tumour activities.

Clin Transl Med · 2022 · PMC8982313 · PMID 35384333

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Surprisingly, BsAb completely abolished HCC1954 tumour growth in NCG mice reconstructed with human peripheral blood mononuclear cells (PBMCs) (Figure 3D,E ), while mAbs and combination treatments alone only slightly suppressed tumour growth and failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.